Market Exclusive

Merit Medical Systems, Inc. (NASDAQ:MMSI) Files An 8-K Financial Statements and Exhibits

Merit Medical Systems, Inc. (NASDAQ:MMSI) Files An 8-K Financial Statements and ExhibitsItem 9.01. Financial Statements and Exhibits.

On February 21, 2017, Merit Medical Systems, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial Report”) in which it (a) furnished, under Item 2.02, a press release announcing the Company’s operating and financial results for the quarter and year ended December 31, 2016 (the “Release”), and (b) furnished, under Item 7.01, a presentation discussing the Company’s operating and financial results for the quarter and year ended December 31, 2016 (the “Presentation”). The Company is filing this Amendment No. 1 on Form 8-K/A (this “Amendment”) in order to furnish the Press Release and the Presentation with corrected entries in two line items of the table providing a reconciliation of GAAP and non-GAAP net income for the year ended December 31, 2016. The corrections do not affect the GAAP or non-GAAP numbers highlighted in the text of the Release or the Presentation.
The updated Exhibits furnished in Item 9.01 herewith supersede in their entirety the Exhibits furnished in Item 9.01 with the Initial Report. The information in this Amendment (including the exhibits furnished herewith) is furnished, to General Instruction B.2. of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.
(d) Exhibits
99.1 Press Release, dated February 21, 2017, entitled “Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016,” including unaudited financial information.
99.2 Conference Call Presentation.
About Merit Medical Systems, Inc. (NASDAQ:MMSI)
Merit Medical Systems, Inc. is a designer, developer, manufacturer and marketer of medical devices used in an array of interventional and diagnostic procedures. The Company operates in two segments: cardiovascular and endoscopy. Its cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases; embolotherapeutic products, and cardiac rhythm management and electrophysiology (CRM/EP) devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its products are used in various clinical areas, such as diagnostic and interventional cardiology; interventional radiology; vascular, general and thoracic surgery; interventional pulmonology; interventional nephrology; oncology, and pain management. Merit Medical Systems, Inc. (NASDAQ:MMSI) Recent Trading Information
Merit Medical Systems, Inc. (NASDAQ:MMSI) closed its last trading session up +0.15 at 29.60 with 385,910 shares trading hands.